Abstract
Most cardiovascular implantable electronic devices (CIEDs) require a ventricular lead to be placed across the tricuspid valve. Tricuspid regurgitation (TR) is an understudied clinical complication of right ventricular lead implantation and its clinical significance is unknown. We review the incidence, predictors, and current management of TR as a complication of ventricular lead implantation. Emerging technologies, including leadless pacing devices and subcutaneous systems, offer the benefit of little or none tricuspid valve disruption.
Original language | English (US) |
---|---|
Pages (from-to) | 150-157 |
Number of pages | 8 |
Journal | Current Heart Failure Reports |
Volume | 12 |
Issue number | 2 |
DOIs | |
State | Published - Mar 4 2015 |
All Science Journal Classification (ASJC) codes
- Emergency Medicine
- Cardiology and Cardiovascular Medicine
- Physiology (medical)